The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

If You or someone you know has been diagnosed with leiomyosarcoma cancer (cancerous uterine fibroids), a gynecologic cancer or occult malignancy (a cancer from an unknown source) following a gynecological surgery such as a hysterectomy or myomectomy that used a laproscopic power morcellator, you may have a claim.
Laparoscopic Power Morcellator (LPM)-Surgeons began using LPMs in the mid-1990s as an alternative to more invasive procedures used to remove uterine fibroids during either a myomectomy or a hysterectomy. An LPM procedure involves the use of a thin, lighted tube equipped with a camera called a laparoscope and a power morcellator, which uses a small blade inside of a hollow cylinder to fragment and remove the specimen through the tube. A special report released by the American College of Obstetricians and Gynecologists (ACOG) in May 2014 estimates that, of the approximately 600,000 hysterectomies done in the U.S. each year:

• <30 percent are performed laparoscopically in women
younger than 40
• <44 percent in women ages 40 to 49, and;
• 16 percent in women ages 50 to 59.

It adds that “the most common indication for hysterectomy is uterine leiomyomas [uterine fibroids], accounting for an estimated 40% of hysterectomies.”According to the FDA, an estimated 1 in 350 women receiving either a hysterectomy or myomectomy will have an unsuspected uterine sarcoma (cancerous uterine fibroids).The potential spread of cancerous tissue due to LPM. Please contact attorney Jamie Sheller if you or a loved one has suffer this type of injury following use of LPM.

Comments for this article are closed.